Overview

Harrison.ai develops AI-driven diagnostic tools for healthcare providers that integrate with existing systems (PACS, RIS, EHR) to act as a second set of eyes, speeding triage and improving accuracy in imaging and pathology. Its products include a flagship radiology decision-support platform (formerly Annalise.ai) that analyzes CT and X-ray studies, Harrison.rad.1, a radiology-focused vision-language model trained on millions of clinical images and reports, and Franklin.ai, an AI pathology assistant that analyzes tissue to identify diseases and guide treatment. The Harrison.ai Open Platform (HOP) lets facilities access multiple AI apps from different vendors through a single integration, reducing platform markups. The company aims to augment clinicians, address radiologist and pathologist shortages, and expand globally—from Australia and the NHS to Asia, Europe, and the U.S.—with a subscription model based on imaging volume.